Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Viral Structure

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.

Size and Structure of Viral Genomes

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

Introduction to Virus

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...

Protein Complex Assembly

Protein Complex Assembly

Proteins can form homomeric complexes with another unit of the same protein or heteromeric complexes with different types. Most protein complexes self-assemble spontaneously via ordered pathways, while some proteins need assembly factors that guide their proper assembly. Despite the crowded intracellular environment, proteins usually interact with their correct partners and form functional complexes.
Many viruses self-assemble into a fully functional unit using the infected host cell to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Participation-Based Academic Performance Is Driven by High-Performing Students and Disengagement of Low-Performing Students.

Medical science educator·2026

Same author

In Vitro Model Characterizing Carcinogenic Progression of HPV-Positive Oropharyngeal Cancer.

Cancers·2026

Same author

Correction: Trehalose supports the growth of Aedes aegypti cells and modifies gene expression and dengue virus type 2 replication.

PLoS pathogens·2025

Same author

Human papillomavirus 16 mitigates <i>Sneathia vaginalis</i>-induced damage to cervical keratinocytes.

mSphere·2025

Same author

Wastewater sequencing from a rural community enables identification of widespread adaptive mutations in a SARS-CoV-2 alpha variant.

Scientific reports·2025

Same author

Current challenges and potential opportunities for interception and prevention of head and neck cancer.

Carcinogenesis·2025

Same journal

Unveiling the hidden virome of Sclerotinia sclerotiorum: New tools and discoveries in mycovirus detection.

Virology·2026

Same journal

ASFV pDP238L negatively regulates type I interferon production via inhibiting the methylation of TBK1.

Virology·2026

Same journal

Divergent poxvirus identified in a non-native black rat from Madagascar.

Virology·2026

Same journal

Genomic and functional characterization of Bacillus phage BCE1 targeting a key gut bacterium in Aedes albopictus larvae.

Virology·2026

Same journal

Viral etiology of orogenital papillomatosis and squamous cell carcinoma in bottlenose dolphins in the southeastern United States.

Virology·2026

Same journal

Orthoflaviviruses in the modern era: Challenges and breakthroughs.

Virology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

Papillomavirus capsid proteins mutually impact structure.

Horng-Shen Chen¹, Michael J Conway, Neil D Christensen

¹Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.

|February 19, 2011

Summary

This summary is machine-generated.

Mutant human papillomavirus (HPV) capsid proteins reveal that changes in one protein affect the other. This suggests vaccines must consider variations in both HPV L1 and L2 capsid proteins for sustained effectiveness.

More Related Videos

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction

Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction

Published on: August 9, 2011

Related Experiment Videos

Last Updated: Jun 4, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus

Published on: July 27, 2021

Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction

Structure of HIV-1 Capsid Assemblies by Cryo-electron Microscopy and Iterative Helical Real-space Reconstruction

Published on: August 9, 2011

Area of Science:

Virology
Vaccine development
Structural biology

Background:

Human papillomavirus (HPV) is a common virus with two major capsid proteins, L1 and L2.
Current HPV vaccines primarily target the L1 protein.
Understanding the structural and antigenic interplay between L1 and L2 is crucial for vaccine efficacy.

Purpose of the Study:

To investigate the structural and antigenic effects of chimeric capsid proteins between HPV16 and HPV18.
To determine how variations in one capsid protein influence the other within the virion.
To assess the implications for HPV vaccine design and effectiveness.

Main Methods:

Construction and analysis of mutant viruses with wild-type and chimeric HPV16/HPV18 capsid proteins.
Assessment of capsid protein expression, genome amplification, and episomal maintenance.
Titration of chimeric viruses and comparison with wild-type.
Utilizing conformation-dependent neutralizing L1 monoclonal antibodies (MAbs) and an L2 capsid surface peptide antibody to probe structural changes.

Main Results:

Mutant and chimeric capsid protein expression, genome amplification, and episomal maintenance were comparable to wild-type.
Chimeric viruses exhibited variations in titers compared to wild-type viruses.
Intertypical mutant chimeric capsid viruses demonstrated that L2 affects L1 structure and L1 affects L2 structure within the virion.
Structural and antigenic changes in one capsid protein were observed to impact the other.

Conclusions:

Variation in one HPV capsid gene significantly impacts the structure and antigenicity of the other capsid protein.
The interplay between L1 and L2 capsid proteins is critical for virion integrity and antigenicity.
For sustained vaccine effectiveness, future strategies should consider variations in both HPV L1 and L2 capsid proteins, not solely the targeted protein.